Home
About
Overview
Sharing Data
ORCID
Help
History (45)
Older patients with myeloma derive similar benefit from autologous transplantation.
Development and Validation of a Novel Preoperative Risk Score to Identify Patients at Risk for Nonhome Discharge after Elective Endovascular Aortic Aneurysm Repair (EVAR).
Concise review: Cancer stem cells and minimal residual disease.
Nurse practitioner organizational climate in primary care settings: implications for professional practice.
Current status of gene therapy for a-1 antitrypsin deficiency.
See All 45 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Current status of gene therapy for a-1 antitrypsin deficiency.
Loring HS, Flotte TR. Current status of gene therapy for a-1 antitrypsin deficiency. Expert Opin Biol Ther. 2015 Mar; 15(3):329-36.
View in:
PubMed
subject areas
Adenoviridae
alpha 1-Antitrypsin
alpha 1-Antitrypsin Deficiency
Animals
Clinical Trials as Topic
Genetic Therapy
Genetic Vectors
Humans
Transgenes
authors with profiles
Terence R Flotte MD